{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:13:20Z","timestamp":1794806000811,"version":"4.9.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111\\u20132314-B-182A-024-MY3"],"award-info":[{"award-number":["111\\u20132314-B-182A-024-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109\\u20102628\\u2010B\\u2010182A\\u2010002"],"award-info":[{"award-number":["109\\u20102628\\u2010B\\u2010182A\\u2010002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital Health System","doi-asserted-by":"publisher","award":["DMR-114\\u2013023"],"award-info":[{"award-number":["DMR-114\\u2013023"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114\\u20132629-B-039\\u2013001-"],"award-info":[{"award-number":["NSTC 114\\u20132629-B-039\\u2013001-"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132314-B-039\\u2013020-MY3"],"award-info":[{"award-number":["NSTC 112\\u20132314-B-039\\u2013020-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114\\u20132622-B-039\\u201300-"],"award-info":[{"award-number":["114\\u20132622-B-039\\u201300-"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113\\u20132314-B-039\\u2013045-MY3"],"award-info":[{"award-number":["NSTC 113\\u20132314-B-039\\u2013045-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX110\\u201310816NC"],"award-info":[{"award-number":["NHRI-EX110\\u201310816NC"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX113\\u201311133NI"],"award-info":[{"award-number":["NHRI-EX113\\u201311133NI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8N1201"],"award-info":[{"award-number":["CMRPG8N1201"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8N1121"],"award-info":[{"award-number":["CMRPG8N1121"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8M1361"],"award-info":[{"award-number":["CMRPG8M1361"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8M1311"],"award-info":[{"award-number":["CMRPG8M1311"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG8N1212"],"award-info":[{"award-number":["CMRPG8N1212"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euroneuro.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T08:48:31Z","timestamp":1765788511000},"page":"112733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-8968","authenticated-orcid":false,"given":"Chieh-Hsin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2025.11.010_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.euroneuro.2024.04.012","article-title":"Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: a narrative review and recommendation for clinical practice","volume":"84","author":"Agid","year":"2024","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0002","series-title":"Structured Clinical Interview For DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0003","article-title":"Minimum clinically important difference in the global assessment functioning in patients with schizophrenia","volume":"17","author":"Amri","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","article-title":"The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations","author":"Andreasen","year":"1989","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fphar.2014.00196","article-title":"Glutathione: new roles in redox signaling for an old antioxidant","volume":"5","author":"Aquilano","year":"2014","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0006","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1203\/00006450-198804000-00006","article-title":"Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse","volume":"23","author":"Batshaw","year":"1988","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0007","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40263-022-00907-3","article-title":"The potential of N-acetyl-l-cysteine (NAC) in the treatment of psychiatric disorders","volume":"36","author":"Bradlow","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0008","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.4049\/jimmunol.0803336","article-title":"Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses","volume":"183","author":"Brahmachari","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1478625","article-title":"Knowledge domain and trends in treatment-resistant schizophrenia (TRS) research based on CiteSpace bibliometrics analysis","volume":"15","author":"Cai","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13111526","article-title":"Schizophrenia and glutathione: a challenging story","volume":"13","author":"Carletti","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105269","article-title":"Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review","volume":"153","author":"Cecerska-Heryc","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41537-025-00604-2","article-title":"Symptomatic and cognitive effects of d-amino acid oxidase inhibitors in patients with schizophrenia: a meta-analysis of double-blind randomized controlled trials","volume":"11","author":"Chang","year":"2025","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0013","doi-asserted-by":"crossref","first-page":"423","DOI":"10.9758\/cpn.2021.19.3.423","article-title":"Novel biomarkers of Alzheimer's disease: based upon N-methyl-D-aspartate receptor hypoactivation and oxidative stress","volume":"19","author":"Chiang","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0014","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s13311-023-01422-z","article-title":"N-acetylcysteine and probenecid adjuvant therapy for traumatic brain injury","volume":"20","author":"Clark","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/schbul\/sbx093","article-title":"N-acetylcysteine in a double-blind randomized placebo-controlled trial: toward biomarker-guided treatment in early psychosis","volume":"44","author":"Conus","year":"2018","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0016","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0017","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1038\/s41380-022-01553-3","article-title":"Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia; response to \"adaptive changes to oxidative stress in schizophrenia by Lena Palaniyappan\"","volume":"27","author":"Cuenod","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103503","article-title":"Changes in levels of the antioxidant glutathione in brain and blood across the age span of healthy adults: a systematic review","volume":"40","author":"Detcheverry","year":"2023","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0019","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/2192568218811922","article-title":"The sin of missing data: is all forgiven by way of imputation?","volume":"8","author":"Dettori","year":"2018","journal-title":"Global Spine J."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0020","first-page":"58","article-title":"Decreased activity of erythrocyte catalase and glutathione peroxidase in patients with schizophrenia","author":"Djordjevic","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0021","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/schbul\/sbab066","article-title":"Timely N-acetyl-cysteine and environmental enrichment rescue oxidative stress-induced parvalbumin interneuron impairments via MMP9\/RAGE pathway: a translational approach for early intervention in psychosis","volume":"47","author":"Dwir","year":"2021","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/mpr.1483","volume":"25","author":"Falissard","year":"2016","journal-title":"Int. J. Methods Psychiatr Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0023","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00406-021-01282-8","article-title":"Improvement in daily functioning after aerobic exercise training in schizophrenia is sustained after exercise cessation","volume":"271","author":"Falkai","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0024","series-title":"Missing Values Analysis and Data Imputation","author":"Garson","year":"2015"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0025","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.2174\/0109298673251025230919105818","article-title":"An update on Glutathione's biosynthesis, metabolism, functions, and medicinal purposes","volume":"31","author":"Gasmi","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0026","first-page":"12","article-title":"How to increase cellular glutathione","author":"Giustarini","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114429","article-title":"Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: a meta-analysis","volume":"309","author":"Goh","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0028","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1073\/pnas.0706778104","article-title":"Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence","volume":"104","author":"Gysin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0029","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.biopsych.2018.06.001","article-title":"d-amino acid oxidase inhibition: a new glutamate twist for clozapine augmentation in schizophrenia?","volume":"84","author":"Harrison","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0031","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.11m07162","article-title":"Minimum clinically important difference in the positive and negative syndrome scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)","volume":"73","author":"Hermes","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0032","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s11064-017-2367-9","article-title":"Assessment of the target engagement and d-serine biomarker profiles of the d-amino acid oxidase inhibitors sodium benzoate and PGM030756","volume":"42","author":"Howley","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0033","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s11064-023-03884-1","article-title":"Determination of d-serine and d-alanine tissue levels in the prefrontal cortex and hippocampus of rats after a single dose of sodium benzoate, a d-amino acid oxidase inhibitor, with potential antipsychotic and antidepressant properties","volume":"48","author":"Huang","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.aqrep.2023.101778","article-title":"Dietary sodium benzoate improves growth, morphology, antioxidant capacity and resistance against Aeromonas hydrophila of Pacific white shrimp (Litopenaeus vannamei)","volume":"33","author":"Huang","year":"2023","journal-title":"Aquaculture Reports"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0035","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1093\/cercor\/bhab107","article-title":"In Vivo brain glutathione is higher in older age and correlates with mobility","volume":"31","author":"Hupfeld","year":"2021","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0036","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0037","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0038","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s40263-022-00959-5","article-title":"Targeting d-amino acid oxidase (DAAO) for the treatment of schizophrenia: rationale and current status of research","volume":"36","author":"Kuo","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0039","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","article-title":"Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of d-amino acid oxidase inhibitor","volume":"70","author":"Lane","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/ijnp\/pyab001","article-title":"Brain activity of benzoate, a d-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, Placebo controlled clinical trial","volume":"24","author":"Lane","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0041","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/pcn.13504","article-title":"Endogenous antioxidants predicted outcome and increased after treatment: a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease","volume":"77","author":"Lane","year":"2023","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173885","article-title":"Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease","volume":"245","author":"Lane","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0043","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2012.12.032","article-title":"Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms","volume":"145","author":"Levine","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0044","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.schres.2007.09.006","article-title":"Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI","volume":"98","author":"Levine","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0045","article-title":"Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition","volume":"15","author":"Li","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0046","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2013.08.010","article-title":"Benzoate, a d-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Lin","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6156","article-title":"Effect of sodium benzoate on cognitive function among patients with behavioral and psychological symptoms of dementia: secondary analysis of a randomized clinical trial","volume":"4","author":"Lin","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0048","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1389450120666191011163539","article-title":"Novel treatment for the most resistant schizophrenia: dual activation of NMDA receptor and antioxidant","volume":"21","author":"Lin","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0049","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fpsyt.2019.00093","article-title":"Early identification and intervention of schizophrenia: insight from hypotheses of glutamate dysfunction and oxidative stress","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0050","first-page":"10","article-title":"Plasma glutathione levels decreased with cognitive decline among people with mild cognitive impairment (MCI): a two-year prospective study","author":"Lin","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0051","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2023.05.001","article-title":"Sodium benzoate: a novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophrenia","volume":"268","author":"Lin","year":"2024","journal-title":"Schizophr Res"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0052","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-025-03492-3","article-title":"Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trial","volume":"15","author":"Lin","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0053","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ijnp\/pyad040","article-title":"Differential impacts of endogenous antioxidants on clinical symptoms and cognitive function in acute and chronic schizophrenia patients","volume":"26","author":"Lin","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0054","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.biopsych.2017.12.006","article-title":"Sodium benzoate, a d-amino acid oxidase inhibitor, added to clozapine for the treatment of schizophrenia: a randomized, double-blind","volume":"84","author":"Lin","year":"2018","journal-title":"Placebo-Controlled Trial. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/pcn.13805","article-title":"Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: secondary analysis of a randomized clinical trial of benzoate","volume":"79","author":"Lin","year":"2025","journal-title":"Psychiatry. Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0056","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/pcn.13841","article-title":"Sodium benzoate, a d-amino acid oxidase inhibitor, improved short-term memory in patients with mild cognitive impairment in a randomized, double-blind, placebo-controlled clinical trial","volume":"79","author":"Lin","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/736837","article-title":"Glutathione homeostasis and functions: potential targets for medical interventions","volume":"2012","author":"Lushchak","year":"2012","journal-title":"J. Amino Acids"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0058","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2215-0366(23)00109-8","article-title":"An international research agenda for clozapine-resistant schizophrenia","volume":"10","author":"Luykx","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10100742","article-title":"Regulation of reactive oxygen species-mediated damage in the pathogenesis of schizophrenia","volume":"10","author":"Madireddy","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/neu.2015.1","article-title":"Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine","volume":"27","author":"Matsuura","year":"2015","journal-title":"Acta. Neuropsychiatr."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0061","doi-asserted-by":"crossref","first-page":"e1944","DOI":"10.1371\/journal.pone.0001944","article-title":"Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study","volume":"3","author":"Matsuzawa","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0062","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S2215-0366(25)00031-8","article-title":"INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia","volume":"12","author":"McCutcheon","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703452","article-title":"Oxidative stress and the pathophysiology and symptom profile of Schizophrenia spectrum disorders","volume":"12","author":"Murray","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0064","doi-asserted-by":"crossref","DOI":"10.31083\/FBL25551","article-title":"The potential mechanism and the role of antioxidants in mitigating oxidative stress in Alzheimer's disease","volume":"30","author":"Naik","year":"2025","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0065","doi-asserted-by":"crossref","first-page":"e1215","DOI":"10.1038\/tp.2017.178","article-title":"Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry","volume":"7","author":"Nucifora","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0066","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41380-022-01550-6","article-title":"Adaptive changes to oxidative stress in schizophrenia","volume":"27","author":"Palaniyappan","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/427318","article-title":"Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?","volume":"2014","author":"Persson","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0068","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/clinpract13040070","article-title":"Potential role of glutathione antioxidant pathways in the pathophysiology and adjunct treatment of psychiatric disorders","volume":"13","author":"Poladian","year":"2023","journal-title":"Clin. Pract."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","article-title":"The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research","volume":"6","author":"Potkin","year":"2020","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-244X-11-124","article-title":"Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients","volume":"11","author":"Raffa","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0071","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3233\/ADR-210001","article-title":"Stimulation of dopamine production by sodium benzoate, a metabolite of cinnamon and a food additive","volume":"5","author":"Rangasamy","year":"2021","journal-title":"J. Alzheimers. Dis. Rep."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010192","article-title":"Sodium benzoate, a metabolite of cinnamon and a food additive, improves cognitive functions in mice after controlled cortical impact injury","volume":"23","author":"Rangasamy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0073","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-2952(93)90386-B","article-title":"Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia","volume":"45","author":"Ratnakumari","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0074","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/15622975.2021.2013041","article-title":"Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: the World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce","volume":"23","author":"Sarris","year":"2022","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2215-0366(25)00001-X","article-title":"Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis","volume":"12","author":"Schneider-Thoma","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0076","article-title":"Assessment of the minimum clinically important difference in symptoms and functions of patients with acute schizophrenia: a post hoc analysis of an open-label, single-arm multicenter study","volume":"12","author":"Si","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0077","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2014.06.021","article-title":"Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \"central hub\" in schizophrenia pathophysiology?","volume":"176","author":"Steullet","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0078","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10715762.2013.781595","article-title":"N-acetylcysteine amide: a derivative to fulfill the promises of N-acetylcysteine","volume":"47","author":"Sunitha","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0079","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41419-023-05645-y","article-title":"Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis","volume":"14","author":"Tan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S2215-0366(23)00406-6","article-title":"Clozapine: past, present, and future","volume":"11","author":"The Lancet","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0081","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.psychres.2013.01.016","article-title":"Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures","volume":"209","author":"Thwin","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0082","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/wps.21316","article-title":"Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts","volume":"24","author":"Tiihonen","year":"2025","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0083","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0084","first-page":"12","article-title":"Cellular compartmentalization, glutathione transport and its relevance in some pathologies","author":"Vazquez-Meza","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071497","article-title":"Sodium benzoate-harmfulness and potential use in therapies for disorders related to the nervous system: a review","volume":"14","author":"Walczak-Nowicka","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0086","doi-asserted-by":"crossref","DOI":"10.47102\/annals-acadmedsg.V38N5p396","article-title":"Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress","volume":"38","author":"Wood","year":"2009","journal-title":"Ann Acad. Med. Singap."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0087","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fnmol.2019.00105","article-title":"Sodium benzoate attenuates secondary brain injury by inhibiting neuronal apoptosis and reducing mitochondria-mediated oxidative stress in a rat model of intracerebral hemorrhage: possible involvement of DJ-1\/Akt\/IKK\/NFkappaB pathway","volume":"12","author":"Xu","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0088","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41537-024-00468-y","article-title":"Variations to plasma H(2)O(2) levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: correlations with psychopathology","volume":"10","author":"Yang","year":"2024","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0089","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0004867419893439","article-title":"Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia","volume":"54","author":"Yolland","year":"2020","journal-title":"Aust. N Z J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2025.11.010_bib0090","article-title":"Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25007898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X25007898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:14:10Z","timestamp":1777583650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X25007898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":90,"alternative-id":["S0924977X25007898"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.11.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. and ECNP. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112733"}}